InvestorsHub Logo
Followers 5
Posts 430
Boards Moderated 0
Alias Born 11/05/2013

Re: None

Wednesday, 01/21/2015 10:43:15 AM

Wednesday, January 21, 2015 10:43:15 AM

Post# of 92948
GE_Healthcare_is_Predicting_a 1 Trillion Dollar Marketplace by_2025

for Regenerative Medical Therapy.
"Could cell therapy be a trillion dollar industry by 2025? GE thinks so..." link below
(I love this story. A TRILLION Dollar Market, heh!)

GE is one of the most successful organizations in
human history. And for GE Healthcare to make such a bold
prediction is hugely significant. This cannot be casually
dismissed, not validly.

A Trillion Dollars in ten years, is a hundred billion
growth each year.

OCAT has the FIRST regenerative therapy that is
FDA Approved!


Being first through the FDA gauntlet is nothing to
be dismissed lightly. This represents two things.

Firstly, it highlights the ENORMOUS lead that OCAT
enjoys over EVERYONE !

Second, it places OCAT in the position of the
Marketplace Gold Standard Bearer. OCAT has
worked with the FDA to invent the regulatory
protocols that all future cell therapy will be judged
against.

This will be rewarded in the marketplace with a
market cap not yet imagined, and right now too
scary to contemplate.

Phase 1 confirms everything going on here.
Complete safety, with indications of efficacy,
is hugely significant. This cannot be casually
dimissed, not validly.
The FDAs own guidelines, state that phase 1 trials
vary from 20 to 80 patients. OCATs 40 patient
phase 1 trial is completely reasonable, and
is more or less typical in size.
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=312.21



There's more work to do, but there's every reason,
every indication, to look positively upon OCAT.

GE Healthcare looks positively upon the entire ReGen
marketplace, of which OCAT is the unchallenged
leader.

OCAT has the FIRST regenerative therapy that is FDA Approved!




http://www.signalsblog.ca/cell-therapy-commercialization-a-view-from-ge-healthcare-on-immunotherapy/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.